Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    PHV 2017 - 14th Pharmacovigilance 2017

    View: 238

    Website http://www.virtueinsight.com/pharma/14th-Pharmacovigilance-2017/ | Want to Edit it Edit Freely

    Category pharma, drug safety, pharmacovigilance

    Deadline: November 09, 2017 | Date: November 09, 2017

    Venue/Country: Mumbai, India

    Updated: 2017-08-11 14:08:36 (GMT+9)

    Call For Papers - CFP

    14th Pharmacovigilance 2017

    “Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management”

    9th November 2017, Kohinoor Continental Hotel, Mumbai, India

    The Pharmacovigilance conference, organized yearly by Virtue Insight, is a unique event where key stakeholders gather with the aim of promoting patient safety and undertaking to continue work towards a more efficient pharmacovigilance system. This is the opportunity to engage and sit alongside the pioneers who are driving forward innovation in pharmacovigilance.

    KEY SPEAKERS:

    • S SADHWANI, Drug controller of Maharashtra and Jt.Commissioner Drug, FDA

    • K. BANGARURAJAN, Deputy Drugs Controller, DDC(I), CDSCO

    • MUZAFFAR AHMAD, Member, Strategic Advisory Board on Health Millenium Alliance (Govt of India) and Member Council of India

    • DAARA B. PATEL, Secretary General, Indian Drug Manufacturers' Association

    • DEEPA ARORA, Vice President - Pharmacovigilance & Global Head - Drug Safety & Risk Management, Lupin

    • JEAN-CHRISTOPHE DELUMEAU, Head of Pharmacovigilance Asia-Pacific, Bayer HealthCare (Singapore)

    • MANISH VERMA, Director and Head of Medical Affairs, South Asia Zone, Sanofi

    • SARABJEET KAUR, Associate Vice President- Pharmacovigilance, APCER Life Sciences

    • AMBRISH SRIVASTAVA, Vice President: Medial Affairs,Clinical Research & Regulatory, Alkem Laboratories

    • VIKRAM GOTA, Associate Professor, ACTREC, Tata Memorial Centre

    • BHASWAT CHAKRABORTY, Senior VP & Chair, Research and Development Core Committee, Cadila

    • AVINASH R. KAKADE, Senior Director and Head of Pharmacovigilance, Cipla

    • SHUBHADEEP SINHA, Vice-President & Head (Global) - Clinical Development, Medical Affairs & Pharmacovigilance, Hetero Labs

    • RAHUL GUPTA, Vice President, Regulatory Affairs, USV

    • SUJAY SURESH KULKARNI, Senior Manager, Medical and Regulatory Affairs, GSK

    • MILIND ANTANI, Partner In-Charge - Pharma LifeSciences, Nishith Desai Associates

    • ABHAY PHANSALKAR, Head Clinical Trials, Cipla

    • DEEPTI SANGHAVI, Assistant Manager-Medical Writing, Tata Consultancy Services

    • RUCHIKA SINGHAL, Business Unit Head, AstraZeneca

    • GURPREET SINGH, Head of Vendor Management in PV, Novartis

    • NIDHI VAISH DAS, Drug Safety, Roche Pharmaceuticals

    • MANOJ SWAMINATHAN, Chief Manager / Head - Global Pharmacovigilance, Piramal

    • SHASHIDHAR SWAMY, Project Manager, Tata Consultancy Services

    • PRANJAL BORDOLOI, AVP - Medical Affairs and Pharmacovigilance, Veeda Clinical Research

    • RAJANI ROKADE, Founder-Director, PharmaSoulz

    • PRASHANT BODHE, Director, CliniSearch

    Plus many more,,

    WHO SHOULD ATTEND:

    Vice Presidents, Directors, CRO’s, Heads and Managers of:

    Pharmacovigilance Strategy, Drug Safety/Risk Management, Information and Clinical Data Management, Clinical Research, Research & Development, Product Safety/Assurance Assessment, Patient Safety & Outcomes Research & Data Analysis, Epidemiology project management, Regulatory Affairs and Compliance, Sales & Marketing, Biotech manufacturers

    Pharmaceutical organizations, Generic pharmaceutical companies, Contract research organizations, Patient recruitment companies, Government- Department of health, Non-profit organizations/ Association, Consultants

    CONFERENCE BOOKING DETAILS:-

    Email – kavithaatvirtueinsight.co.in or TEL: + 91 9940791115

    • Early-Bird Discount until 26 September 2017 - 1 Delegate Pass – (INR 6,000 + GST (18%) per delegate).

    • Standard Price from 27 September 2017– 1 or 2 Delegates – (INR 7,000 + GST (18%) per delegate).

    • Group Discounts – 3 or 4 Delegates – (INR 6,500 + GST (18%) per delegate)

    • Group Discounts – 5 and above Delegates – (INR 6,000 + GST (18%) per delegate)

    • Spot Registration on the day of the Conference – 1 Day Conference - (INR 8,000 + GST (18%) per delegate)

    • Conference Sponsor & Exhibition Stalls are also available. We also have sponsorship opportunities available for the event which gives you an opportunity to speak/exhibit and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts.

    REGISTRATION PROCESS:-

    In order to register simply fill in the last page of the attached file and email us back to me or you can simply email me your invoice details in the below mentioned format;

    • Company Name & Address:

    • GST number (if applicable):

    • Attendee Name:

    • Job Title:

    • Contact Number:

    Be a part of this conference and explore benefit-risk management strategies and patient-centric approaches and how you can tackle the challenges of social media and drug safety legislation globally.


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.